Boiron SA (EPA:BOI)

France flag France · Delayed Price · Currency is EUR
26.50
+0.90 (3.52%)
Apr 28, 2026, 5:35 PM CET
7.72%
Market Cap 444.47M
Revenue (ttm) 501.11M
Net Income (ttm) 32.64M
Shares Out 17.36M
EPS (ttm) 1.88
PE Ratio 13.62
Forward PE 12.45
Dividend 1.20 (4.69%)
Ex-Dividend Date Jun 3, 2026
Volume 17,883
Average Volume 4,572
Open 25.40
Previous Close 25.60
Day's Range 25.40 - 26.90
52-Week Range 20.85 - 32.25
Beta 0.25
RSI 52.97
Earnings Date Jul 17, 2026

About Boiron

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products, including medical devices, invitro diagnostics, herbal medicine, food supplements, cosmetics, and CBD-based products. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for a... [Read more]

Sector Healthcare
Founded 1932
Employees 2,736
Stock Exchange Euronext Paris
Ticker Symbol BOI
Full Company Profile

Financial Performance

In 2025, Boiron's revenue was 501.11 million, an increase of 2.78% compared to the previous year's 487.56 million. Earnings were 32.64 million, an increase of 187.96%.

Financial Statements

News

There is no news available yet.